Clostridium difficile accounts for 15-25% of cases of antibiotic-assoc
iated diarrhea (AAD) and for virtually all cases of antibiotic-associa
ted pseudo-membranous colitis (PMC), This anaerobic bacterium is also
carried in the gastro-intestinal tract of less than 3% of the normal a
dult population and can be isolated from the feces of 50-70% asymptoma
tic neonates, Since recent years, C. difficile has been identified as
the leading cause of nosocomial diarrhea in adults, Pathogenesis relie
s on a disruption of the normal bacteria flora of the colon, a coloniz
ation with C. difficile and the release of toxins that cause mucosal d
amage and inflammation. Incidence of C. difficile intestinal disorders
varies between 1 to 30 per thousand patient admissions, Risk factors
for C. difficile-associated diarrhea include antimicrobial therapy, ol
der age (>65 years), intensive care, nasogastric tube, anti-acid use,
and length of hospital stay, Nosocomial transmission of C. difficile v
ia orofecal route occurs in 3-30% of total patient admissions but it o
ften remains asymptomatic, Environmental contamination and carriage of
the organism on the hands of hospital staff are common, Measures that
are recommended to reduce cross-infection rely on an accurate and rap
id diagnosis, implementation of enteric isolation, use of disposable g
loves, hand washing with a suitable disinfectant (e.g. chlorhexidine)
and daily environmental disinfection, C. difficile is a common cause o
f infectious diarrhea and should be therefore systematically investiga
ted in patients with nosocomial diarrhea.